Table 8.

Antibiotics for systemic use (J01) within DU90% segment expressed in the number of DDDs/TID, and the cost per defined daily dose (DDD) in Euros within and beyond DU90% segment in south backa district (SBD).

No	ATC	INN	%	Defined daily doses per 1,000 inhabitants per day	Cost (euro)/DDD
1	J01CA04	Amoxicillina	21.17	5.71	0.21
2	J01DB01	Cefalexina	13.24	3.57	0.70
3	J01AA02	Doxycyclinea	11.47	3.09	0.12
4	J01EE01	Co-trimoxazolea	6.91	1.86	0.24
5	J01FA10	Azythromycina	6.38	1.72	1.52
6	J01MA02	Ciprofloxacina	5.17	1.39	1.52
7	J01CE02	Phenoxymethylpenicillina	4.98	1.34	0.65
8	J01GB03	Gentamicin	4.27	1.15	1.15
9	J01CR02	Amoxicillin+clavulanic acida	4.25	1.15	0.83
10	J01CA01	Ampicillin	4.15	1.12	0.31
11	J01DD08	Cefiximea	4.01	1.08	2.16
12	J01FA09	Clarithromycina	2.89	0.78	0.86
13	J01MB04	Pipemidic acida	2.14	0.58	2.11
DU90% 1–13 (average)			91.04	24.54	0.95
Others 14–37 (average)			8.96	2.40	1.89
TOTAL 1–37			100.00	26.94	1.56

ATC, anatomical therapeutic chemical; INN, International Nonproprietary Name.

^aDrugs fully reimbursed by the Republic Fund for Health Insurance of Serbia in 2008.